HomeIndustriesHealthcare'Exciting Race' Between LLY & NVO, Tariffs Remain Long-Term Overhang

'Exciting Race' Between LLY & NVO, Tariffs Remain Long-Term Overhang

Lee Brown sees lots of potential in the weight loss drug space, noting Eli Lilly (LLY) and Novo Nordisk (NVO) as the two companies he expects to lead. He points to "incredible" discounts and expanded access to GLP-1s as indicators these companies will see wider moats for their products. Lee adds that the recent pharma tariffs from the Trump administration will benefit U.S.-based companies, but adds that tariffs will prove to be a long-term overhang. Tom White offers an example options trade for Eli Lilly.

Morning Trade Live

06 Oct 2025

SHARE

ON AIR
6:00 pm
The Wrap
replay
education
12:00 am
Your First Trade
REPLAY
education
12:30 am
Your First Trade
REPLAY
education
1:00 am
Inside the Mind of a Trader
REPLAY
education
1:30 am
Inside the Mind of a Trader
REPLAY
education
2:00 am
Inside the Mind of a Trader
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
The Wrap
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Fast Market
REPLAY
9:00 am
Next Gen Investing
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
education
11:00 am
Your First Trade
REPLAY
education
11:30 am
Your First Trade
REPLAY
education
12:00 pm
Your First Trade
REPLAY
education
12:30 pm
Your First Trade
REPLAY
education
1:00 pm
Your First Trade
REPLAY
education
1:30 pm
Your First Trade
REPLAY
education
2:00 pm
Your First Trade
REPLAY
education
2:30 pm
Your First Trade
REPLAY
3:00 pm
Market Overtime
REPLAY
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
ON AIR
6:00 pm
The Wrap
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
The Wrap
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor